Enliven Therapeutics
ELVN
#5225
Rank
C$1.67 B
Marketcap
$34.30
Share price
-3.42%
Change (1 day)
119.74%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$30.9 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are C$30.9 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$34.43 M-84.15%
2022-12-31C$0.21 B9.14%
2021-12-31C$0.19 B3.19%
2020-12-31C$0.19 B